Po-Huang Chen

46PUBLICATIONS
69CO-AUTHORS
Molecular targetsArtificial life and complex adaptive systemsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Sep 29, 2026
Selective serotonin reuptake inhibitors and immune checkpoint blockade in solid tumors: A target trial emulation with pan-cancer transcriptomic analyses.

|Sep 29, 2026
Artificial Intelligence-Derived Electrocardiographic Age Enhances Stroke Risk Stratification in Patients With Atrial Fibrillation With a CHA2DS2-VA Score of 1.

|Sep 26, 2026
Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.

|Jul 28, 2026
Comparative Effectiveness of Adjuvant XELOX Versus TS-1 Monotherapy After D2 Gastrectomy for Stage III Gastric Cancer: A Real-World Nationwide Cohort Study.

|Jul 16, 2026
Effect of Remdesivir on Mortality in Mechanically Ventilated COVID-19 Patients: A Target Trial Emulation Using Inverse Probability of Treatment Weighting.

|Jun 26, 2026
Long-Term Cognitive Impairment After CAR-T Therapy Versus Autologous Stem Cell Transplantation: A Propensity Score-Matched Cohort Study.

Pageof 8

Frequent Collaborators

26 joint publications

Hong-Jie Jhou

21 joint publications

Cho-Hao Lee

6 joint publications

Ming-Shen Dai

6 joint publications

Wei-Cheng Chang